Iproteos

Société

À propos de votre organisation / profil

Iproteos is determined to improve human health by creating therapeutics to fulfil unmet medical needs. Our proprietary platform IPROTech allows the development of novel highly permeable and stable compounds to specifically address undruggable targets in less time and cost. The effectiveness of IPROTech has been proved by Iproteos’ pipeline of compounds mainly for Central Nervous System (CNS) indications. Our most advanced program is for Cognitive Impairment related with CNS diseases such as Schizophrenia or Parkinson’s disease, and will enter clinical trials in early 2019.

Website www.iproteos.com

Twitter and Linkedin @iproteos